We are live on ! Find out more
LA

Lau Associates Portfolio holdings

AUM $201M
1-Year Est. Return 26.29%
This Fund
S&P 500
This Quarter Est. Return
+9.37%
1 Year Est. Return
+26.29%
3 Year Est. Return
+44.49%
5 Year Est. Return
+59.98%
10 Year Est. Return
AUM
$201M
AUM Growth
+$11.8M
Cap. Flow
+$1.1M
Cap. Flow %
0.55%
Top 10 Hldgs %
53.57%
Holding
99
New
3
Increased
6
Reduced
35
Closed
5

Sector Composition

1 Technology 22.92%
2 Healthcare 11.95%
3 Consumer Staples 8.61%
4 Energy 8.58%
5 Financials 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
76
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$311K 0.15%
5,266
-134
-2% -$7.83K
FFIV icon
77
F5
FFIV
$23.1B
$307K 0.15%
2,200
PNC icon
78
PNC Financial Services
PNC
$101B
$306K 0.15%
1,915
VZ icon
79
Verizon
VZ
$182B
$289K 0.14%
4,712
-100
-2% -$6.03K
SPGI icon
80
S&P Global
SPGI
$133B
$273K 0.14%
1,000
FSLR icon
81
First Solar
FSLR
$22.8B
$271K 0.13%
4,850
UNP icon
82
Union Pacific
UNP
$179B
$271K 0.13%
1,498
MRSH
83
Marsh
MRSH
$87.8B
$263K 0.13%
2,359
APD icon
84
Air Products & Chemicals
APD
$65.8B
$256K 0.13%
1,090
SLB icon
85
SLB Ltd
SLB
$70.3B
$251K 0.13%
6,235
-1,134
-15% -$40.5K
VEA icon
86
Vanguard FTSE Developed Markets ETF
VEA
$226B
$226K 0.11%
+5,140
New +$219K
DAL icon
87
Delta Air Lines
DAL
$55.4B
$220K 0.11%
3,760
DIS icon
88
Walt Disney
DIS
$170B
$207K 0.1%
+1,432
New +$200K
GE icon
89
GE Aerospace
GE
$364B
$167K 0.08%
2,999
DRRX
90
DELISTED
DURECT Corp
DRRX
$137K 0.07%
3,600
FON
91
DELISTED
SPRINT CORP FON COM
FON
$130K 0.06%
25,000
ACGN
92
DELISTED
Aceragen Inc
ACGN
$28K 0.01%
904
+301
+50% +$11.2K
ABBV icon
93
AbbVie
ABBV
$450B
-6,251
Closed -$473K
CGC
94
Canopy Growth
CGC
$397M
-1,386
Closed -$318K
HD icon
95
Home Depot
HD
$338B
-880
Closed -$204K
TTOO
96
DELISTED
T2 Biosystems, Inc
TTOO
-3
Closed -$32K
CGI
97
DELISTED
Celadon Group Inc
CGI
-20,000
Closed -$25K

Similar funds

Lau Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Lau Associates held 99 positions worth $201M, up 6.3% from $189M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Lau Associates's Q4 2019 filing shows 3 new, 6 increased, 35 reduced and 5 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K. The largest sale was Corteva, an estimated $643K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Lau Associates's largest Q4 2019 buy was Vanguard FTSE Developed Markets ETF: 5,140 shares worth $226K.
  • Lau Associates added most to JPMorgan Ultra-Short Income ETF in Q4 2019, an estimated $2.88M increase.
  • Lau Associates's biggest Q4 2019 reduction was Corteva, cutting an estimated $643K.
  • Lau Associates fully exited AbbVie in Q4 2019, selling an estimated $473K.
  • Lau Associates's ten largest holdings make up 54% of its $201M portfolio in Q4 2019.
  • Lau Associates opened 3 new positions and closed 5 in Q4 2019.
  • Lau Associates's portfolio value rose 6.3% quarter-over-quarter to $201M.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.